Issue Date: June 6, 2016
Virus helps unmask anticancer drug to attack brain tumors
For patients with extremely aggressive brain tumors called high-grade gliomas, treatment options are limited, especially for recurring forms of the disease.
But results from a Phase I clinical trial show promise for a treatment that combines a virus and a prodrug (Sci. Transl. Med. 2016, DOI: 10.1126/scitranslmed.aad9784).
Gliomas exist in two forms in the brain— as a solid tumor and as tumor . . .
To view the rest of this content, please log in with your ACS ID.
- Chemical & Engineering News
- ISSN 0009-2347
- Copyright © American Chemical Society